Sign in Subscribe
Asian medicine

Idiopathic Pulmonary Fibrosis Linked to Increased Risk of Cardiovascular Disease

Strategic Insights

— 1 min read

Research conducted at the Beijing University of Chinese Medicine has identified a significant association between idiopathic pulmonary fibrosis (IPF) and cardiovascular disease. According to the study, patients with IPF are at a higher risk of developing cardiovascular comorbidities, which can affect drug tolerability and health outcomes. The systematic review and meta-analysis, published in the journal Frontiers in Medicine, aimed to quantify the association between IPF and cardiovascular disease. The study's findings emphasize the need for systematic screening and risk reduction strategies in IPF patients.

Key Takeaways:

  • The study included 28 observational studies, comprising 29 case-control/cross-sectional datasets and four cohort datasets.
  • The pooled odds ratio (OR) for case-control/cross-sectional datasets was 2.44 (95% CI 1.84-3.24), indicating a positive association between IPF and cardiovascular disease.
  • The study found that IPF patients are at a higher risk of developing cardiovascular comorbidities, which can affect drug tolerability and health outcomes.
  • The study emphasized the urgent need for systematic screening and risk reduction strategies in IPF patients.
  • The research was conducted by a team of researchers from Beijing University of Chinese Medicine, led by Weili Tan.
  • Additional authors for the study include Yang Li, Yangyini Zhang, Fang Cao, Zhisong Wu, Yang Jiao, and Jie Niu.

Statistics:

  • The pooled odds ratio (OR) for case-control/cross-sectional datasets was 2.44 (95% CI 1.84-3.24).
  • The relative risk (RR) for cohort datasets was calculated, but not provided in the news report.
  • The study included 28 observational studies, comprising 29 case-control/cross-sectional datasets and four cohort datasets.
  • The Newcastle-Ottawa Scale (NOS) was used to assess study quality.
  • The quality of the studies included in the meta-analysis was evaluated using the NOS, with a mean score of 7.5 (range 3-9).

Sources:

  • Tan, W., Li, Y., Zhang, Y., Cao, F., Wu, Z., Jiao, Y., ... & Niu, J. (2025). Cardiovascular disease in idiopathic pulmonary fibrosis: a systematic review and meta-analysis of observational studies. Frontiers in Medicine, 12, 1653435.
  • Frontiers in Medicine. (2025). Volume 12, Article 1653435.
  • Beijing University of Chinese Medicine. (n.d.). Graduate School.
  • NewsRx. (2025, October 20). Findings in the Area of Idiopathic Pulmonary Fibrosis Reported from Beijing University of Chinese Medicine (Cardiovascular disease in idiopathic pulmonary fibrosis: a systematic review and meta-analysis of observational studies). Cardiovascular Week, p 27.

Read more